Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial

Clinical trial NCT06854224 · RECRUITING

Trial details

NCT number: NCT06854224
Sponsor: Marianne Goodman
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Suicide Risk Major Depressive Disorder (MDD)

Start date: 2025-09-01
Primary completion: 2027-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.